1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 4,415 | 4,480 | 13:03 | |
| 4,420 | 4,480 | 27.06. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 17.06. | ONWARD Medical NV: ONWARD Medical Builds Commercial Momentum for the ARC-EX System and Reinforces its Brain-Computer Interface Leadership in Q1 2025 | 339 | GlobeNewswire (Europe) | EINDHOVEN, the Netherlands, June 17, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD and US OTCQX: ONWRY), the leading neurotechnology company pioneering therapies to restore movement,... ► Artikel lesen | |
| 11.06. | ONWARD Medical NV: ONWARD Medical Announces Results of its Annual General Meeting of Shareholders | 837 | GlobeNewswire (Europe) | THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014)
Shareholders approve all proposed resolutions
EINDHOVEN,... ► Artikel lesen | |
| 11.06. | ONWARD Medical NV: ONWARD Medical Schedules Webcast to Provide Q1 2025 Business Update and Year-To-Date Highlights | 561 | GlobeNewswire (Europe) | EINDHOVEN, the Netherlands, June 11, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD and US OTCQX: ONWRY), the leading neurotechnology company pioneering therapies to restore movement,... ► Artikel lesen | |
| 21.05. | ONWARD Medical NV: ONWARD Medical Advances Brain-Computer Interface Leadership with Fourth and Fifth Successful BCI Implants | 513 | GlobeNewswire (Europe) | Groundbreaking procedures extend ONWARD's leadership in the rapidly emerging brain-computer interface (BCI) fieldARC-BCI Therapy is designed to restore thought-driven movement after spinal cord injury... ► Artikel lesen | |
| ONWARD MEDICAL Aktie jetzt für 0€ handeln | |||||
| 30.04. | ONWARD Medical NV: ONWARD Medical Convocation of the 2025 Annual General Meeting of Shareholders and Proposed Resolutions | 657 | GlobeNewswire (Europe) | EINDHOVEN, the Netherlands, April 30, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD and US OTCQX ONWRY), the medical technology company creating innovative spinal cord stimulation therapies... ► Artikel lesen | |
| 28.04. | ONWARD Medical NV: ONWARD Medical Announces Release of 2024 Annual Report | 457 | GlobeNewswire (Europe) | EINDHOVEN, the Netherlands, April 28, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement... ► Artikel lesen | |
| 24.04. | ONWARD Medical NV: ONWARD Medical Establishes US ADR Program and Begins Trading on OTCQX Best Market | 424 | GlobeNewswire (Europe) | Sponsored Level 1 ADR program facilitates trading by US investors following recent FDA clearance and commercial launch
BNY will be ADR depositary bank
Ticker symbol for US investors is ONWRY
EINDHOVEN... ► Artikel lesen | |
| 23.04. | OTC Markets Group Welcomes ONWARD Medical N.V. to OTCQX | 257 | GlobeNewswire (Europe) | NEW YORK, April 23, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced ONWARD Medical... ► Artikel lesen | |
| 01.04. | ONWARD Medical NV: ONWARD Medical Reports Full Year 2024 Financial and Operating Results and Shares 2025 Year-to-Date Highlights | 570 | GlobeNewswire (Europe) | Received FDA authorization and recorded first commercial sales of ARC-EX System
Secured strategic investment from Ottobock and extended cash runway for two years
Gained exclusive rights to premier... ► Artikel lesen | |
| 26.03. | ONWARD Medical NV: ONWARD Medical Announces First-in-Human Use of ARC-IM Lumbar Lead Designed to Restore Standing, Stepping, and Lower Limb Mobility | 433 | GlobeNewswire (Europe) | The ARC-IM Lumbar Lead is the second model in the ARC-IM Lead family to be used in a clinical feasibility study
The Company is building a portfolio of purpose-designed leads to optimize delivery... ► Artikel lesen | |
| 19.03. | ONWARD Medical NV: ONWARD Medical Schedules Reporting of Full Year 2024 Financial Results and Business Update Webcast | 542 | GlobeNewswire (Europe) | EINDHOVEN, the Netherlands, March 19, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement... ► Artikel lesen | |
| 04.03. | ONWARD Medical NV: ONWARD Medical to Advance Parkinson's Disease Pipeline with Support from The Michael J. Fox Foundation and US Department of Defense | 909 | GlobeNewswire (Europe) | The Michael J. Fox Foundation for Parkinson's Research is supporting a study addressing mobility challenges in Parkinson's disease; the first participant was enrolled in late 2024
A US Department... ► Artikel lesen | |
| 25.02. | ONWARD Medical NV: ONWARD Medical Announces Publication of One-Year Study Showing Benefit of Sustained Access to ARC-EX Therapy | 501 | GlobeNewswire (Europe) | Study shows significant functional improvements after one year of ARC-EX Therapy
Improvements were observed throughout one-year treatment period with no plateau
Results demonstrate the importance... ► Artikel lesen | |
| 29.01. | ONWARD Medical NV: ONWARD Medical's ARC-EX System Now Available on US Veterans Affairs Online Procurement Platforms | 560 | GlobeNewswire (Europe) | ONWARD ARC-EX System for spinal cord injury is now available for purchase through VA Federal Supply Schedule and GSA Advantage platforms
Partnership with Lovell Government Services is providing... ► Artikel lesen | |
| 13.01. | ONWARD Medical NV: ONWARD Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference | 568 | GlobeNewswire (Europe) | CEO Dave Marver to Provide Company Update Wednesday, January 15, 2025EINDHOVEN, the Netherlands, Jan. 13, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company... ► Artikel lesen | |
| 09.01. | ONWARD Medical NV: ONWARD Medical Announces First Commercial Sales of ARC-EX System | 730 | GlobeNewswire (Europe) | UW Medicine and Next Steps Chicago both purchased systems in late December 2024
ARC-EX is the first and only FDA approved technology indicated to improve hand strength and sensation in people with... ► Artikel lesen | |
| 19.12.24 | ONWARD Medical NV: ONWARD Medical Receives FDA De Novo Classification and US Market Authorization for World's First Non-Invasive Spinal Cord Stimulation System for People with Chronic Spinal Cord Injury | 662 | GlobeNewswire (Europe) | THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014)
ARC-EX System is the first and only FDA approved technology... ► Artikel lesen | |
| 12.12.24 | ONWARD Medical NV: ONWARD Medical Ranks in Top 15 Percent Globally for Corporate Sustainability | 889 | GlobeNewswire (Europe) | EcoVadis silver medal recognizes Company's environmental and social impact
Demonstrates ongoing commitment to integrating sustainable business practices
EINDHOVEN, the Netherlands, Dec. 12,... ► Artikel lesen | |
| 26.11.24 | ONWARD Medical NV: ONWARD Medical Provides Q3 2024 Update and Year-to-Date Highlights | 604 | GlobeNewswire (Europe) | Raised EUR 50 million in new capital with cornerstone investment from Ottobock, now the Company's top investor
Signed exclusive license with CEA to develop and commercialize WIMAGINE Brain-Computer... ► Artikel lesen | |
| 19.11.24 | ONWARD Medical NV: ONWARD Medical Awarded Grant to Study Potential for ARC-BCI Therapy to Restore Movement after Stroke | 611 | GlobeNewswire (Europe) | Grant supports the first clinical trials studying the potential for brain-computer interface (BCI) and artificial intelligence (AI) technology to restore thought-driven movement after stroke
Funding... ► Artikel lesen |
1 2 Weiter >>
39 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 42,590 | +0,95 % | Aktienmarkt: Fresenius SE & Co. KGaA-Aktie kann sich nicht behaupten (42,16 €) | Der Anteilsschein von Fresenius SE & Co. KGaA notiert am Mittwoch leichter. Die Aktie kostete zuletzt 42,16 Euro. Für Inhaber von Fresenius+Co KgaA ist der heutige Handelstag bisher nicht sonderlich... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 48,300 | +0,52 % | BERENBERG stuft FMC FRESENIUS MEDICAL CARE AG auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Fresenius Medical Care (FMC) von 55 auf 60 Euro angehoben und die Einstufung auf "Buy" belassen. Analystin Victoria Lambert... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 46,900 | +0,13 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 57,00 | +1,06 % | UBS stuft CARL ZEISS MEDITEC AG auf 'Neutral' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat Carl Zeiss Meditec auf "Neutral" belassen. In Gesprächen mit Investoren in Europa habe er ein gestiegenes Interesse an Medizintechnikunternehmen... ► Artikel lesen | |
| ECKERT & ZIEGLER | 67,85 | +2,03 % | Leichte Zugewinne bei der Eckert&Ziegler-Aktie (65,60 €) | Die Eckert&Ziegler-Aktie notiert heute etwas fester. Das Wertpapier kostete zuletzt 65,60 Euro. Eine Verteuerung in Höhe von 1,75 Euro erfreut derzeit die Aktionäre von Eckert&Ziegler. Zur Stunde kostet... ► Artikel lesen | |
| DRAEGERWERK | 67,10 | +0,15 % | Dräger-Aktie legt um 0,15 Prozent zu (67,10 €) | Im deutschen Wertpapierhandel liegt das Wertpapier von Dräger zur Stunde im Plus. Der jüngste Kurs betrug 67,10 Euro. Das Wertpapier von Dräger verzeichnet aktuell ein Kursplus von 0,15 Prozent. Es... ► Artikel lesen | |
| MEDTRONIC | 73,67 | +0,23 % | Kaum Impulse für die Medtronic plc-Aktie (73,7742 €) | Der Kurs der dem Anteilsschein von Medtronic plc kommt kaum von der Stelle. Das Papier kostete zuletzt 85,73 US-Dollar. Die Wertschätzung der privaten und institutionellen Anlegern für die Aktie von... ► Artikel lesen | |
| INTUITIVE SURGICAL | 459,00 | +0,71 % | Intuitive Surgical Aktie: Sondermeldung sorgt für starke Verunsicherung. Das ist der Grund und so müssen Anleger heute handeln! | ||
| UNITEDHEALTH | 263,95 | -0,02 % | Dividendenbekanntmachungen (24.06.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) COMPAGNIE DE L ODET SA FR0000062234 - 4,4 EUR DOM DEVELOPMENT SA PLDMDVL00012 7 PLN 1,6374 EUR ELBIT SYSTEMS LTD IL0010811243 0... ► Artikel lesen | |
| GERRESHEIMER | 48,080 | +1,26 % | Deutsche Pfandbriefbank, Gerresheimer, Hugo Boss, Renk, Rheinmetall, Symrise - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| TELADOC HEALTH | 7,160 | -0,28 % | Aktien-Trading 4 Dummies - 3 Aktien. 2 Experten. 0 Langeweile (Hims & Hers, Teladoc & XTI Aerospace) | ||
| THERMO FISHER | 349,20 | +0,13 % | Adial Pharmaceuticals, Inc: Adial Pharmaceuticals Secures U.S.-Based Manufacturing Through Agreements with Cambrex and Thermo Fisher Scientific for Drug Substance and Drug Product Supply | Scope of Agreement with Cambrex to Provide Ondansetron HCL Drug Substance Under FDA Approved Drug Master File Scope Of Agreement With Thermo Fisher to Provide Manufacturing Services Including Demonstration... ► Artikel lesen | |
| RHOEN-KLINIKUM | 11,900 | +1,71 % | 100.000 Operationen seit Einzug in den Neubau - RHÖN-KLINIKUM Campus Bad Neustadt zieht positive Bilanz | Bad Neustadt a.d. Saale (ots) - Hohe Operationszahlen spiegeln medizinische Kompetenz und strukturelle Stärke wider: Seit dem Einzug in den hochmodernen Neubau 2018/2019 hat der RHÖN-KLINIKUM Campus... ► Artikel lesen | |
| ROKU | 73,28 | -1,32 % | This 30-second fix made my Roku TV run like new again (and why it works) | ||
| ESSILORLUXOTTICA | 233,70 | -0,38 % | BERNSTEIN RESEARCH stuft EssilorLuxottica auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung für EssilorLuxottica auf "Market-Perform" mit einem Kursziel von 245 Euro belassen. Luca Solca befasste sich in... ► Artikel lesen |
ONWARD MEDICAL NV gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 4,525 Euro und damit +1,69 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ONWARD MEDICAL NV finden Sie auf Wallstreet Online.